Stock Updates

How has AstraZeneca PLC:(NYSE:AZN) performed recently?

AstraZeneca PLC (NYSE: AZN) is a large market cap stock with a market cap of 85826.27. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 38.34, a forward P/E of 12.61 and EPS of 0.88. At a stock price of 33.66 (1.69%) it has a dividend yield of 2.67%.

EPS growth for the last five years have been -16.70%, more recently this last year it has grown by 128.90%. The next year growth is going to be about -10.10% and more long-term -1.00% after five years. EPS growth quarter over quarter is -100.40%. Sales growth for the past five years have been -5.80% and sales growth quarter over quarter is -11.20%.

For performance, AstraZeneca PLC the past week has seen a gain of 1.88%. For the last month performance for AstraZeneca PLC is 0.33%. While the last quarter is 23.45% and half year, 18.35%. Finally for the year, performance is 4.74%.

The 52-week high for AstraZeneca PLC, is at -2.66%, and for the 52-week low it comes to a value of 26.47%. The 20-day simple moving average is 4.07% and 11.60% for the 200-day simple moving average.

Volatility for the week is at 2.03%, and for the month it is 1.40%. AstraZeneca PLC, has a target price of 35.5.

In terms of debt, long term debt/equity is 1.22, and for total debt/equity AstraZeneca PLC has 1.3. The gross margin is 82.20%, while operating margin is 15.00%, the profit margin is 9.20%. The current ratio is 0.9 and the quick ratio is 0.8.

Insider ownership is at 0.50%, with instituitional ownership at 12.20%. AstraZeneca PLC has a payout ratio of 108.10%. With the total shares outstanding coming to 2549.8. The shares float is *TBA, with the float short at *TBA, with short ratio coming to 4.8.

In terms of returns, the return on assets see AstraZeneca PLC, get 3.70%, with its returns on investment at 11.50%. Return on equity is 13.90%. So will the investors see the target price of 35.5, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment